AbClon extends contract end date to Nov. 30 from Sept. 30 in correction filing

• AbClon corrected its voluntary disclosure on a single sales and supply contract, extending the end date to 2026-11-30.
• The contract value remains 424,056,300 won, equal to 9.0% of 2025 standalone revenue.
• The deal covers reagent and lab equipment supply to South Korea’s National Institute of Food and Drug Safety Evaluation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbClon Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930900401), on September 30, 2026, and is solely responsible for the information contained therein.